Biocon expands generic formulations portfolio, launches Tacrolimus capsules in US
Biocon Ltd, an innovation-led global bio pharmaceuticals company has announced the launch of Tacrolimus capsules in the US market. Tacrolimus, […]
Say something
Tags: Biocon Ltd, ehealth news
Biocon drug for COVID 19 ALZUMAb® (Itolizumab) to cost Rs 7,950 per vial
Biocon Ltd, an innovation-led global biopharmaceuticals company, presenting its key insights into the results of the Itolizumab for treating patients […]
Itolizumab to save many COVID 19 patients, asserts Biocon Ltd
After India’s drug regulator approved Itolizumab, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory […]
Suresh Subramanian to lead Biocon’s Branded Formulations business
Strengthening leadership, Biocon Ltd., a biopharmaceutical company has appointed Suresh Subramanian as the Senior Vice President and Head of the […]
-
-
Flipkart Health+ App Launched
06-04-2022
